theblood
PrivateLast Round
Seed
May 10, 2024
Total Funding Raised
$1.06M
Momentum Score
25 /100
Company Overview
theblood is a FemTech company that provides an at-home test kit for non-invasive menstrual blood analysis to help women monitor their health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, D2C Brands, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
theblood Comps
Public and private peers based on sector, stage, and business model.
theblood Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 10, 2024 | ||||
| Pre Seed | Mar 14, 2023 |
theblood Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RoX Health | Pre Seed |
theblood Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about theblood's valuation, stock price, and market status.
